Double oxygen-sensing vector system for robust hypoxia/ ischemia-regulated gene induction in cardiac muscle in vitro and in vivo

Molecular Therapy

Volumn 16, Issue 9, 2008, Pages 1594-1601

  Fomicheva, Ekaterina V ^a   Turner, Immanuel I ^a   Edwards, Terri G ^a   Hoff, Janet ^a   Arden, Eric ^a   D'Alecy, Louis G ^a   Metzger, Joseph M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CIS ACTING ELEMENT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOUBLE OXYGEN SENSING VECTOR SYSTEM; GENE EXPRESSION; GENE INDUCTION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; OXYGEN SENSING; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT;

ANIMALS; ANOXIA; CELLS, CULTURED; CYTOMEGALOVIRUS; GENE EXPRESSION REGULATION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIA; LUCIFERASES; MYOCARDIUM; MYOCYTES, CARDIAC; OXYGEN; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RESPONSE ELEMENTS; TRANSDUCTION, GENETIC;

ANIMALIA; CYTOMEGALOVIRUS;

EID: 50549096758     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.136     Document Type: Article

References (46)

1. Yenari, MA and Sapolsky, RM (2005). Gene therapy in neurological disease. Methods Mol Med 104: 75-88.
2. Woo, SL, Skarlatos, SI, Joyce, MM, Croxton, TL and Qasba, P (2006). Critical resources for gene therapy in Heart, Lung, and Blood Diseases Working Group. Mol Ther 13: 641-643.
3. Williams, ML and Koch, WJ (2004). Viral-based myocardial gene therapy approaches to alter cardiac function. Annu Rev Physiol 66: 49-75.
4. Pachori, AS, Melo, LG and Dzau, VJ (2006). Gene therapy: Role in myocardial protection. Handb Exp Pharmacol: 335-350.
5. Hermonat, PL and Mehta, JL (2004). Potential of gene therapy for myocardial ischemia. Curr Opin Cardiol 19: 517-523.
6. Hata, JA, Williams, ML and Koch, WJ (2004). Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization. J Mol Cell Cardiol 37: 11-21.
7. Corno, AF, Boone, Y, Mallabiabarrena, I, Augstburger, M, Tozzi, P, Ferrari, E et al. (2004). Myocardial and pulmonary effects of aqueous oxygen with acute hypoxia. Ann Thorac Surg 78: 956-960; discussion 956-960.
8. Boast, K, Binley, K, Iqball, S, Price, T, Spearman, H, Kingsman, S et al. (1999). Characterization of physiologically regulated vectors for the treatment of ischemic disease. Hum Gene Ther 10: 2197-2208.
9. Goverdhana, S, Puntel, M, Xiong, W, Zirger, JM, Barcia, C, Curtin, JF et al. (2005). Regulatable gene expression systems for gene therapy applications: Progress and future challenges. Mol Ther 12: 189-211.
10. Binley, K, Kan, O, White, J and Naylor, S (2003). Exploiting the hypoxia response. Curr Opin Mol Ther 5: 650-656.
11. Wenger, RH (2000). Mammalian oxygen sensing, signalling and gene regulation. J Exp Biol 203: 1253-1263.
12. Erbel, PJ, Card, PB, Karakuzu, O, Bruick, RK and Gardner, KH (2003). Structural basis for PAS domain heterodimerization in the basic helix - loop - helix-PAS transcription factor hypoxia-inducible factor. Proc Natl Acad Sci USA 100: 15504-15509.
13. Huang, LE, Gu, J, Schau, M and Bunn, HF (1998). Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992.
14. Krek, W (2000). VHL takes HIF's breath away. Nat Cell Biol 2 E121-E123.
15. Bruick, RK and McKnight, SL (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340.
16. Ohh, M, Park, CW, Ivan, M, Hoffman, MA, Kim, TY, Huang, LE et al. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol 2: 423-427.
17. Bruick, RK (2003). Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev 17: 2614-2623.
18. Bruick, RK and McKnight, SL (2002). Transcription. Oxygen sensing gets a second wind. Science 295: 807-808.
19. Iyer, M, Wu, L, Carey, M, Wang, Y, Smallwood, A and Gambhir, SS (2001). Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci USA 98 14595-14600.
20. Tang, Y, Jackson, M, Qian, K and Phillips, MI (2002). Hypoxia inducible double plasmid system for myocardial ischemia gene therapy. Hypertension 39: 695-698.
21. Tang, Y (2005). Gene therapy for myocardial ischemia using the hypoxia-inducible double plasmid system. Methods Mol Med 112 37-47.
22. Phillips, MI, Tang, Y, Schmidt-Ott, K, Qian, K and Kagiyama, S (2002). Vigilant vector: Heart-specific promoter in an adeno-associated virus vector for cardioprotection. Hypertension 39: 651-655.
23. Tang, YL, Tang, Y, Zhang, YC, Agarwal, A, Kasahara, H, Qian, K et al (2005). A hypoxia-inducible vigilant vector system for activating therapeutic genes in ischemia. Gene Ther 12: 1163-1170.
24. Tang, YL, Tang, Y, Zhang, YC, Qian, K, Shen, L and Phillips, MI (2004). Protection from ischemic heart injury by a vigilant heme oxygenase-1 plasmid system. Hypertension 43: 746-751.
25. Rodriguez-Porcel, M, Gheysens, O, Chen, IY, Wu, JC and Gambhir, SS (2005). Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Mol Ther 12: 1142-1147.
26. Samsamshariat, SA, Samsamshariat, ZA and Movahed, MR (2005). A novel method for safe and accurate left anterior descending coronary artery ligation for research in rats. Cardiovasc Revasc Med 6: 121-123.
27. Rising, CL and D'Alecy, LG (1989). Hypoxia-induced increases in hypoxic tolerance augmented by beta-hydroxybutyrate in mice. Stroke 20 1219-1225.
28. Zwemer, CF, Song, MY, Carello, KA and D'Alecy, LG (2007). Strain differences in response to acute hypoxia: CD-1 versus C57BL/6J mice. J Appl Physiol 102: 286-293.
29. Gupta, MP, Gupta, M and Zak, R (1994). An E-box/M-CAT hybrid motif and cognate binding protein(s) regulate the basal muscle-specific and cAMP-inducible expression of the rat cardiac alpha-myosin heavy chain gene. J Biol Chem 269: 29677-29687.
30. Dong, X, Liu, J, Zheng, H, Glasford, JW, Huang, W, Chen, QH et al. (2004). In situ dynamically monitoring the proteolytic function of the ubiquitin-proteasome system in cultured cardiac myocytes. Am J Physiol Heart Circ Physiol 287: H1417-H1425.
31. Safran, M, Kim, WY, O'Connell, F, Flippin, L, Gunzler, V, Horner, JW et al. (2006). Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: Assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci USA 103: 105-110.
32. Iyer, M, Salazar, FB, Lewis, X, Zhang, L, Carey, M, Wu, L et al. (2004). Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 10: 545-552.
33. Ray, S, Paulmurugan, R, Hildebrandt, I, Iyer, M, Wu, L, Carey, M et al. (2004). Novel bidirectional vector strategy for amplification of therapeutic and reporter gene expression. Hum Gene Ther 15: 681-690.
34. Harada, H, Kizaka-Kondoh, S, Itasaka, S, Shibuya, K, Morinibu, A, Shinomiya, K et al. (2007). The combination of hypoxia-response enhancers and an oxygen-dependent proteolytic motif enables real-time imaging of absolute HIF-1 activity in tumor xenografts. Biochem Biophys Res Commun 360: 791-796.
35. Tang, Y, Schmitt-Ott, K, Qian, K, Kagiyama, S and Phillips, MI (2002). Vigilant vectors: Adeno-associated virus with a biosensor to switch on amplified therapeutic genes in specific tissues in life-threatening diseases. Methods 28: 259-266.
36. Chan, DA, Sutphin, PD, Yen, SE and Giaccia, AJ (2005). Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha. Mol Cell Biol 25: 6415-6426.
37. Koivunen, P, Hirsila, M, Kivirikko, KI and Myllyharju, J (2006). The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J Biol Chem 281 28712-28720.
38. D'Angelo, G, Duplan, E, Boyer, N, Vigne, P and Frelin, C (2003). Hypoxia up-regulates prolyl hydroxylase activity: A feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem 278 38183-38187.
39. Townsend, D, Blankinship, MJ, Allen, JM, Gregorevic, P, Chamberlain, JS and Metzger, JM (2007). Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure. Mol Ther 15: 1086-1092.
40. Day, SM, Westfall, MV, Fomicheva, EV, Hoyer, K, Yasuda, S, La Cross, NC et al. (2006). Histidine button engineered into cardiac troponin I protects the ischemic and failing heart. Nat Med 12: 181-189.
41. Petersen, SE, Jerosch-Herold, M, Hudsmith, LE, Robson, MD, Francis, JM, Doll, HA et al. (2007). Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric magnetic resonance imaging. Circulation 115: 2418-2425.
42. Friehs, I, Barillas, R, Vasilyev, NV, Roy, N, McGowan, FX and del Nido, PJ (2006). Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart. Circulation 114: I290-I295.
43. Post, DE and Van Meir, EG (2001). Generation of bidirectional hypoxia/ HIF-responsive expression vectors to target gene expression to hypoxic cells. Gene Ther 8: 1801-1807.
44. Westfall, MV, Rust, EM, Albayya, F and Metzger, JM (1997). Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes. Methods Cell Biol 52: 307-322.
45. Contag, CH, Spilman, SD, Contag, PR, Oshiro, M, Eames, B, Dennery, P et al. (1997). Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem Photobiol 66: 523-531.
46. Blankinship, MJ, Gregorevic, P, Allen, JM, Harper, SQ, Harper, H, Halbert, CL et al. (2004). Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther 10: 671-678.